One in Four Canadians in Long-Term Care Receive Unprescribed Antipsychotics

A recent report has unveiled a troubling statistic: approximately one in four Canadians residing in long-term care facilities have been prescribed antipsychotic medications without a proper diagnosis of psychosis. This alarming finding not only raises questions about medication practices within these facilities but also highlights the potential risks associated with the use of such powerful drugs among vulnerable populations.

Understanding the Context of Long-Term Care

Long-term care homes serve as essential support systems for individuals who require assistance with daily living due to age, disability, or chronic illness. However, these facilities often face scrutiny regarding their medication practices and overall care quality. The recent report by the Canadian Institute for Health Information (CIHI) reveals that Canada has a higher rate of antipsychotic medication usage in long-term care compared to other developed countries.

The use of antipsychotics typically aims to manage symptoms related to psychosis, such as delusions and hallucinations. Yet, it has become increasingly common to prescribe these medications to residents suffering from dementia or other cognitive impairments to control aggressive behaviors. This practice raises ethical concerns about the appropriateness and necessity of such treatments.

Risk Factors Associated with Antipsychotic Medications

According to the CIHI report, the inappropriate use of antipsychotics can lead to several serious side effects, including:

• Adverse drug reactions
• Cognitive decline
• Increased risk of falls
• Potentially fatal complications

Health professionals emphasize that the decision to use antipsychotics should be made with caution, carefully weighing the benefits against the potential risks. For instance, drowsiness, a common side effect, can significantly impact a resident's quality of life, leading to reduced social interactions and overall satisfaction.

Long-Term Care in Canada: Current Statistics

As of 2024-25, about 24% of long-term care residents in Canada were administered antipsychotic medications without a corresponding diagnosis of psychosis. This figure is particularly concerning in light of previous trends showing a decline in such prescriptions prior to the COVID-19 pandemic. The pandemic, however, saw a resurgence in these rates, prompting further examination of care practices within facilities.

Statistics Canada projects that by 2030, more than 20% of Canadians will be 65 or older, increasing the demand for long-term care services. This demographic shift poses challenges, including staffing shortages and a potential decline in overall care quality.

Evaluating Medication Use in Long-Term Care

The CIHI report also indicates that certain provinces, such as Manitoba and Quebec, did not provide sufficient data for inclusion in the study. However, the available data suggests a pressing need for more stringent oversight regarding medication practices in long-term care homes.

To address the inappropriate use of antipsychotic medications, various organizations, including the Appropriate Use Coalition, have come together to advocate for better medication management strategies. This coalition aims to establish benchmarks for acceptable medication use, targeting a maximum of 15% of residents receiving antipsychotics without a psychosis diagnosis by 2024-25.

Understanding the Broader Implications of Antipsychotic Prescriptions

High rates of antipsychotic prescriptions can have cascading effects on healthcare systems and the quality of care. For instance, residents may experience

• A decline in mental and physical health
• Increased dependence on caregivers
• Reduced engagement in social and recreational activities

These factors not only diminish the quality of life for residents but also place additional burdens on caregiving staff, who must manage the complex needs of their patients.

Addressing Staffing Challenges in Long-Term Care

The CIHI report highlights another pressing issue: staffing shortages. In 2023-24, approximately 8% of total hours worked by direct care staff in long-term care homes were overtime. This equated to over three million overtime hours, illustrating the considerable strain on the workforce. Increased staffing levels are critical for enhancing resident safety and care quality.

Experts suggest that better staffing can lead to:

• More individualized attention for residents
• Improved support for daily tasks, such as mobility and personal hygiene
• Greater opportunities for social interaction and engagement

Addressing these staffing challenges is crucial for creating a supportive environment where residents can thrive.

Looking Ahead: The Future of Long-Term Care in Canada

As the demand for long-term care continues to rise, it is imperative that policymakers and healthcare professionals prioritize the well-being of residents. This includes re-evaluating medication practices, improving staffing levels, and investing in training for caregivers on the appropriate use of medications.

Continued monitoring and research are necessary to ensure that the health and safety of long-term care residents is upheld. Effective communication between families, caregivers, and healthcare providers can also foster a collaborative approach to care that respects the dignity and needs of individuals living in these facilities.